(Q37598917)

21 August 2017

High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods (English)

1 reference

21 August 2017

1 reference

1

Sharon D Yeatts

1 reference

21 August 2017

Yuko Y Palesch

2

1 reference

PMCID

3932442

21 August 2017

Claudia S Moy

series ordinal

3

1 reference

PMCID

3932442

21 August 2017

Magdy Selim

series ordinal

4

1 reference

21 August 2017

1 October 2013

1 reference

21 August 2017

1 reference

21 August 2017

19

1 reference

21 August 2017

2

1 reference

21 August 2017

257-266

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-013-9861-y

21 August 2017

0 references

cites work

Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: the role of iron

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Recombinant activated factor VII for acute intracerebral hemorrhage.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Heme and iron metabolism: role in cerebral hemorrhage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Progression of mass effect after intracerebral hemorrhage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Cryptic multiple hypotheses testing in linear models: overestimated effect sizes and the winner's curse

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Autophagy after experimental intracerebral hemorrhage

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Iron and iron-handling proteins in the brain after intracerebral hemorrhage.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Iron chelator deferoxamine alters iron-regulatory genes and proteins and suppresses osteoblast phenotype in fetal rat calvaria cells

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Effect of treatment of elevated blood pressure on neurological deterioration in patients with acute intracerebral hemorrhage.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Molecular signatures of brain injury after intracerebral hemorrhage

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932442

Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage

1 September 2018

1 reference

12 December 2020

Applying a phase II futility study design to therapeutic stroke trials

1 reference

12 December 2020

Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes

1 reference

12 December 2020

Chronological changes of perihematomal edema of human intracerebral hematoma

1 reference

12 December 2020

Anti-adrenergic medications and edema development after intracerebral hemorrhage

1 reference

12 December 2020

10.1007/S12028-013-9861-Y

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

PMCID

3932442